
Honasa Consumer Calls Off ₹135 Crore Fluence Pharma Acquisition, Reaffirms Nutraceuticals Strategy
Honasa Consumer, the parent of Mamaearth and The Derma Co, has called off its proposed ₹135 crore acquisition of Fluence Pharma, saying it remains committed to its nutraceuticals strategy and will continue to evaluate other opportunities in the category.








